ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1773

The Card9-Neutrophil Signaling Axis Is Critical to Induction of Th17-Mediated Arthritis in SKG Mice

Ruth Napier1, Ellen Lee 1, Emily Vance 1, Beatitude Steffen 2, Shimon Sakaguchi 3 and Holly Rosenzweig 4, 1Oregon Health & Science University and Portland VA Hospital, Portland, OR, 2Oregon Health & Science University and Portland VA Hospital, Portland, 3Osaka University, Osaka, Japan, 4Oregon Health & Science University and Portland VA Hospital, Oregon

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: card9, Mouse model, Rheumatoid arthritis (RA), SKG and arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 4M093: RA – Animal Models (1770–1775)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Caspase recruitment domain-containing protein 9 (CARD9) is an adaptor protein downstream of C-type lectin receptor signaling within myeloid cells. CARD9 is critical for anti-fungal immunity; yet also linked to inflammatory diseases including ankolysing spondylitis and Crohn’s Disease. Here, we investigated the role of Card9 in autoimmunity as modeled in SKG mice, which develop T cell-mediated arthritis in response to microbial triggers.

Methods: SKG and Card9-/-SKG mice,were injected with zymosan (1.5 mg), clinically monitored for arthritis, and histologically analyzed for joint pathology. At 8 wk post-zymosan, CD4+ T cells from draining lymph nodes were stimulated in vitro with PMA/ionomycin and Th effector subsets were quantified by intracellular cytokine staining and flow cytometry. For adoptive T cell transfers, splenic CD4+ T cells purified from naïve mice by immunomagnetic selection were intravenously injected (4×106) into nude (nu/nu) recipients who were injected 24h later with zymosan. For lavage studies, peritoneal fluid collected 4h post-zymosan was analyzed for cellular (ie. neutrophils) and non-cellular (ie. chemokine/cytokine) content by flow cytometry and ELISA. Neutrophils were depleted in SKG mice with anti-Ly6G (1A8) or isotype control (2A3) beginning 24h prior to zymosan and every 2d for 11d. For all studies, three independent experiments were performed (n=5-6 mice/genotype), and data analyzed using non-parametric statistics.

Results: After zymosan injection, SKG mice developed chronic arthritis while Card9-/-SKG mice developed no detectable arthritis. Card9-/-SKG mice had reduced numbers of T cells in pLN including reduced CD4+ T effector cells (Th17, Th1, Th22), and decreased IL-17A in synovial fluid. The mechanism by which Card9 suppresses arthritis is T cell-extrinsic since Card9-deficient and –sufficient T cells had similar abilities to induce arthritis. Given the known anti-fungal role for Card9 within myeloid cells we examined acute myeloid cell responses to zymosan. Within 4h of zymosan injection Card9-/-SKG mice had dramatically reduced proportions of peritoneal neutrophils, whereas the dendritic cells and macrophage responses were comparable in Card9-/-SKG vs. SKG mice.   Neutrophil chemoattractants (CXLC1, CXCL2) or inflammatory cytokines (IL-1b, IL-6, IL-23) levels in the peritoneum were not altered by Card9-deficiency. However, Card9-deficient neutrophils had significant reduction in activation status (CD62L) and in their ability to undergo degranulation as determined by mobilization of secondary (CD66b) and primary granules (CD63). Neutrophil depletion during the priming stage delayed arthritis onset.

Conclusion: These data reveal a previously unconsidered role for Card9-signaling within neutrophils in response to environmental triggers in conferring susceptibility to arthritis in SKG mice.


Disclosure: R. Napier, None; E. Lee, None; E. Vance, None; B. Steffen, None; S. Sakaguchi, None; H. Rosenzweig, None.

To cite this abstract in AMA style:

Napier R, Lee E, Vance E, Steffen B, Sakaguchi S, Rosenzweig H. The Card9-Neutrophil Signaling Axis Is Critical to Induction of Th17-Mediated Arthritis in SKG Mice [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-card9-neutrophil-signaling-axis-is-critical-to-induction-of-th17-mediated-arthritis-in-skg-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-card9-neutrophil-signaling-axis-is-critical-to-induction-of-th17-mediated-arthritis-in-skg-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology